6533b859fe1ef96bd12b8371

RESEARCH PRODUCT

Comprehensive management of risk factors in peripheral vascular disease. Expert consensus

Pilar Caridad Morata BarradoCarlos Guijarro HerraizJorge Jesús Martín CañueloJ.f. Merino-torresCristina Tejera PérezMaría ÁNgeles Martínez LópezTeresa Rama MartínezSergio Cinza-sanjurjoMª Dolores Aicart BortC. BrotonsVicente Pascual FusterEmilio OrtegaTomás Ripoll VeraCarmen Peinado AdiegoAlberto CorderoCarlos Jericó AlbaLuis Castilla-guerraFrancisco Valls-rocaPablo Antonio Toledo FríasRosa María Sánchez-hernándezAntonio Pérez PérezÁNgel Brea HernandoJuan Girbés BorrásMiguel ÁNgel Prieto DíazJ.m. MostazaMaría Soledad Navas De SolísElisa Velasco ValdazoEstíbaliz Jarauta SimónJuan Carlos Ferrer GarcíaJosé Manuel Ruiz PalomarFrancisco M. Morales-pérezJulio Sánchez ÁLvarezJavier De Juan BagudáNúria Muñoz RivasElías DelgadoManuel Frías VargasOvidio Muñiz GrijalvoEsther Doiz ArtázcozPedro ValdivielsoAdriana Saltijeral CerezoRebeca Reyes GarcíaManuel Rodríguez PiñeroBeatriz Jiménez MuñozLuis Leiva HernandoEnrique Rodilla SalaAlfonso Barquilla GarcíaJose Daniel Mosquera LozanoCarlos Santos AltozanoAntonio Miguel Hernández MartínezAlejandro Berenguel SenénManuel Gargallo FernándezMaría Gloria Cánovas MolinaJulio Antonio Carbayo HerenciaIgnacio Párraga MartínezElena Iborra OrtegaAurora García LerínVicente Ignacio Arrarte EstebanVivencio BarriosJose Polo GarcíaManuel Antonio Botana LópezRuth Sánchez OrtigaManuel Suárez TembraMiguel Brito BanfielÁNgel Carlos Matía CubilloJosé María Cepeda RodrigoDaniel Escribano PardoP. BeatoM. ComellasInés Gil GilR. CampuzanoMartín Ruiz OrtizVíctor Rodríguez Sáenz De BuruagaAgustín Blanco EchevarríaRosario Lorente CalvoJosé Manuel Comas SamperSergio HeviaNatalia De La FuenteJuan Cosin SalesRafael Vidal-pérezVirginia Bellido CastañedaN. PlanaAmelia CarroCarlos LahozMagdalena León MazorraSergio Martínez HervasMaria Seoane VicenteMelina Vega De CenigaM. Antonia Pérez LázaroSergio Jansen ChaparroAntonio Ruiz GarcíaIsabel Ayala ViguerasMiren Morillas BuenoEsther Merino LanzaAndrés Galarza TapiaMarta Casañas MartínezDaiana Ibarretxe GerediagaMaría Durán MartínezJosé Antonio RubioÓScar Moreno-pérezAndrés García LeónLuis Estallo LalienaEduardo Carrasco CarrascoVicente Pallarés-carrataláAlberto Zamora CervantesJavier EscaladaJuan Carlos Obaya RebollarMercedes Guerra RequenaJosé Antonio Quindimil VázquezPedro J. Pinés CorralesCarlos Escobar CervantesLisardo García-martínAlbert ClaràJose María Fernández Rodriguez-lacinMiguel Turégano YedroFrancisco Javier Félix RedondoLuis MasmiquelJacinto Fernández PardoLaura Calsina JuscafresaMaría Eugenia López ValverdeEva María Pereira LópezFátima Almagro MúgicaAgustín Medina Falcón

subject

medicine.medical_specialtyConsensusVascular diseasebusiness.industryArterial diseaseDelphi methodExpert consensusGeneral MedicineDiseasemedicine.diseaseQuit smokingPeripheral Arterial DiseaseRisk FactorsMultidisciplinary approachDiabetes MellitusmedicineHumansAnkle Brachial IndexMedical prescriptionIntensive care medicinebusiness

description

There is currently a degree of divergence among the main clinical practice guidelines on the management of risk factors for peripheral arterial disease (PAD). This project aims to gain understanding of the management of PAD risk factors in clinical practice and to reach a multidisciplinary consensus on the strategies to be followed in order to optimize its identification, treatment, and follow-up.A multidisciplinary consensus following the Delphi methodology.Professionals (n = 130) with extensive experience in PAD participated in this consultation. The results suggest that in order to optimize the control of risk factors, efforts should be aimed at: (1) promoting the involvement and awareness of all specialists in the identification of and screening for the disease; (2) guaranteeing the possibility of evaluating the ankle-brachial index (ABI) in all the medical specialties involved; (3) promoting strategies for patients to quit smoking through the use of drugs, programs, or referrals to specialized units; (4) promoting an appropriate Mediterranean-based diet and the prescription of daily exercise; (5) raising awareness of the importance of ensuring LDL cholesterol values below 70 mg/dL, especially in symptomatic but also in asymptomatic patients (55 mg/dL following the publication of the ESC/EAS guide); (6) recommending the use of antiplatelet therapy in asymptomatic patients with diabetes mellitus (DM) and/or a pathological ABI; and (7) protocolizing the annual evaluation of ABI in high-risk patients.This document presents the 22 agreed-upon strategies which are intended to help professionals optimize multidisciplinary management of PAD risk factors.

yearjournalcountryeditionlanguage
2020-09-16Revista Clínica Española (English Edition)
https://doi.org/10.1016/j.rceng.2020.11.011